Olympus, a precision technology leader in designing and delivering innovative solutions in Medical and Surgical Products among other core businesses, announces that its revolutionary ScopeGuide® technology can now be used within the United States. The new instrument available from Olympus America Inc...
Chief Executive Comments On Blood Service Remaining In-House, UK
5/25/2011
UNISON, the UK's largest union, welcomes NHS Blood and Transplant (NHSBT) chief executive Lynda Hamlyn's comments over the blood service remaining in-house, but has warned that the campaign to keep the whole service from privatisation is far from over...
Veridex Launches CELLTRACKS(R) Circulating Melanoma Cell Kit For Research Use
5/25/2011
Veridex, LLC today announced the launch of the CELLTRACKS® Circulating Melanoma Cell (CMC) kit, providing research scientists with a fast, convenient and reliable way to capture CMCs for research studies...
Promising Interim Results For New Therapy For Bladder Cancer
5/25/2011
Clinical trials for a new bladder cancer therapy show promising interim results. Lead researcher Alvaro Morales says that the breakthrough using the drug Urocidin follows thirty years of his research in this important area. "I am optimistic about the results of the trial," says Dr...
Discovery Of Simple Method Of Dealing With Harmful Radioactive Iodine
5/25/2011
Iodine radioisotopes are produced by fission of uranium fuel in a nuclear reactor. Radioactive iodine is of concern because it is highly mobile in the environment and selective uptake by the thyroid gland can pose a significant cancer risk following long term exposure. Furthermore, iodine-129, which is a type of radioactive iodine, has an extremely long half life of 15...
Quick, Low-Cost, And Portable Microchip Developed For Immune Monitoring And Clinical Applications
5/25/2011
There's a wealth of health information hiding in the human immune system. Accessing it, however, can be very challenging, as the many and complex roles that the immune system plays can mask the critical information that is relevant to addressing specific health issues...
Cancer Research UK and Cancer Research Technology - the charity's development and commercialisation arm - have partnered with Centella Therapeutics, Inc. of Palo Alto, California, to develop, manufacture and trial a promising new drug, CEN-209 in cancer patients with solid tumours...
Centella Therapeutics, Inc., a subsidiary of Varian Medical Systems, Inc. (NYSE: VAR), and Auckland UniServices Ltd...
New Breast Cancer Treatment Launched In UK
5/25/2011
Halaven(TM) Black Triangle Drug (eribulin), a novel treatment for patients with locally advanced or metastatic breast cancer who have progressed after at least two chemotherapeutic regimens for advanced disease is launched today in the United Kingdom...
Conference Reviews Cancer Prevention Benefits Of Prophylactic Aspirin
5/25/2011
Recent evidence linking aspirin use with a reduced risk of several cancers could change the risk benefits analysis in favour of wider use of aspirin, concluded a meeting organized by the Aspirin Foundation. The report of the meeting "Aspirin, Salicylates and Cancer", held November 2011 at the Royal Society of Medicine...